LENSAR (LNSR) Competitors $9.29 -0.60 (-6.07%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$9.85 +0.56 (+5.97%) As of 02/21/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LNSR vs. SMLR, TCMD, NNOX, NPCE, CVRX, ZIMV, NYXH, SMTI, AVR, and RCELShould you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Semler Scientific (SMLR), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), NeuroPace (NPCE), CVRx (CVRX), ZimVie (ZIMV), Nyxoah (NYXH), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), and AVITA Medical (RCEL). These companies are all part of the "medical equipment" industry. LENSAR vs. Semler Scientific Tactile Systems Technology Nano-X Imaging NeuroPace CVRx ZimVie Nyxoah Sanara MedTech Anteris Technologies Global AVITA Medical LENSAR (NASDAQ:LNSR) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment. Do insiders and institutionals hold more shares of LNSR or SMLR? 40.2% of LENSAR shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 38.5% of LENSAR shares are held by company insiders. Comparatively, 30.2% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to LNSR or SMLR? In the previous week, Semler Scientific had 5 more articles in the media than LENSAR. MarketBeat recorded 8 mentions for Semler Scientific and 3 mentions for LENSAR. Semler Scientific's average media sentiment score of 0.65 beat LENSAR's score of 0.50 indicating that Semler Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LENSAR 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Semler Scientific 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend LNSR or SMLR? LENSAR presently has a consensus target price of $8.00, suggesting a potential downside of 13.89%. Semler Scientific has a consensus target price of $71.00, suggesting a potential upside of 48.72%. Given Semler Scientific's higher probable upside, analysts clearly believe Semler Scientific is more favorable than LENSAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, LNSR or SMLR? LENSAR has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Is LNSR or SMLR more profitable? Semler Scientific has a net margin of 72.65% compared to LENSAR's net margin of -34.03%. Semler Scientific's return on equity of 50.77% beat LENSAR's return on equity.Company Net Margins Return on Equity Return on Assets LENSAR-34.03% -49.02% -21.12% Semler Scientific 72.65%50.77%47.04% Which has better earnings & valuation, LNSR or SMLR? Semler Scientific has higher revenue and earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLENSAR$42.16M2.56-$14.38M-$1.46-6.36Semler Scientific$56.29M7.86$20.58M$4.919.72 Does the MarketBeat Community prefer LNSR or SMLR? LENSAR received 3 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 38.46% of users gave LENSAR an outperform vote. CompanyUnderperformOutperformLENSAROutperform Votes538.46% Underperform Votes861.54% Semler ScientificOutperform Votes266.67% Underperform Votes133.33% SummarySemler Scientific beats LENSAR on 14 of the 16 factors compared between the two stocks. Get LENSAR News Delivered to You Automatically Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LNSR vs. The Competition Export to ExcelMetricLENSARSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$114.87M$4.71B$5.84B$9.15BDividend YieldN/A39.90%4.75%3.85%P/E Ratio-6.3627.4125.4719.00Price / Sales2.5653.20447.5876.30Price / CashN/A51.1038.0134.83Price / Book3.136.577.644.62Net Income-$14.38M$90.13M$3.18B$245.85M7 Day Performance-11.52%-2.20%-1.99%-2.68%1 Month Performance11.52%-2.17%-0.42%-2.19%1 Year Performance112.59%15.26%16.51%12.84% LENSAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNSRLENSAR1.6211 of 5 stars$9.29-6.1%$8.00-13.9%+98.1%$114.87M$42.16M-6.36110News CoverageSMLRSemler Scientific2.9026 of 5 stars$49.67+0.4%$71.00+42.9%+3.7%$460.44M$68.18M24.23120Earnings ReportTCMDTactile Systems Technology2.3372 of 5 stars$17.33+2.3%$23.00+32.7%+8.4%$415.92M$274.42M26.66980Earnings ReportAnalyst DowngradeAnalyst RevisionNews CoverageNNOXNano-X Imaging1.9357 of 5 stars$6.72-11.0%$17.50+160.4%-31.8%$388.28M$9.90M-7.91190Gap DownHigh Trading VolumeNPCENeuroPace2.2011 of 5 stars$12.31+1.8%$14.80+20.2%-11.8%$367.43M$76.45M-12.31170Insider TradeNews CoverageHigh Trading VolumeCVRXCVRx2.7813 of 5 stars$15.09+4.1%$17.83+18.2%-36.8%$366.14M$51.29M-5.61160ZIMVZimVie1.8389 of 5 stars$13.14-0.2%$19.50+48.4%-29.8%$362.65M$451.29M-1.002,600Upcoming EarningsNYXHNyxoah2.8581 of 5 stars$10.53-0.4%$17.00+61.4%-32.1%$358.65M$5.08M-5.63110High Trading VolumeSMTISanara MedTech2.1665 of 5 stars$35.02-0.7%$47.00+34.2%-10.3%$306.08M$64.99M-35.3760AVRAnteris Technologies GlobalN/A$7.99+1.9%$16.50+106.5%N/A$287.16MN/A0.00138RCELAVITA Medical1.5394 of 5 stars$10.57+20.4%$18.00+70.3%-44.0%$277.15M$50.14M-4.74130Analyst ForecastInsider TradeNews CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies Semler Scientific Competitors Tactile Systems Technology Competitors Nano-X Imaging Competitors NeuroPace Competitors CVRx Competitors ZimVie Competitors Nyxoah Competitors Sanara MedTech Competitors Anteris Technologies Global Competitors AVITA Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LNSR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.